昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

休市中 07-18 16:08:33

21.850

+0.150

+0.69%

最高22.450	最低21.450	成交量378.30万
今开22.000	昨收21.700	日振幅4.61%
总市值163.66亿	流通市值26.00亿	总股本7.49亿
成交额8,287万	换手率3.18%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":21.85,"timestamp":1752826113787,"preClose":21.7,"halted":0,"volume":3782959,"delay":0,"floatShares":119000000,"shares":749000000,"eps":0.10930316514805485,"marketStatus":"休市中","change":0.15,"latestTime":"07-18 16:08:33","open":22,"high":22.45,"low":21.45,"amount":82866031,"amplitude":0.046083,"askPrice":21.9,"askSize":23400,"bidPrice":21.85,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":0.5591632949795556,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":7,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":21.7,"dividendRate":0.001373,"openAndCloseTimeList":[[1752802200000,1752811200000],[1752814800000,1752825600000]],"volumeRatio":0.4080509684647337,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":26.62,"timestamp":1752822000000,"preClose":26.9,"halted":0,"volume":23410400,"delay":0,"premium":"-24.91"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2552345131","title":"徐慕浩2025年二季度表现，泰信竞争优选混合基金季度涨幅1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552345131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552345131?lang=zh_cn&edition=full","pubTime":"2025-07-18 12:55","pubTimestamp":1752814528,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2025年二季度末，基金经理徐慕浩旗下共管理2只基金，本季度表现最佳的为泰信竞争优选混合，季度净值涨1.31%。徐慕浩在担任泰信竞争优选混合基金经理的任职期间累计任职回报145.76%，平均年化收益率为16.39%。持有期间的估算收益率为97.47%，持有期间东方盛虹在2020年到2021年的年报归属净利润增幅达496.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800017525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2552643877","title":"昭衍新药07月17日获主力加仓1001.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552643877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552643877?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:15","pubTimestamp":1752740156,"startTime":"0","endTime":"0","summary":"07月17日, 昭衍新药股价涨5.85%，报收21.70元，成交金额1.7亿元，换手率6.56%，振幅9.27%，量比0.81。昭衍新药今日主力资金净流入1001.0万元，上一交易日主力净流入961.5万元。该股近5个交易日上涨9.56%，主力资金累计净流入1861.6万元；近20日主力资金累计净流入2033.7万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717172021a6af7075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717172021a6af7075&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2551150854","title":"昭衍新药07月15日遭主力抛售935.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551150854","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551150854?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:16","pubTimestamp":1752567369,"startTime":"0","endTime":"0","summary":"07月15日, 昭衍新药股价跌1.93%，报收20.30元，成交金额2.8亿元，换手率11.95%，振幅12.71%，量比1.27。昭衍新药今日主力资金净流出935.3万元，上一交易日主力净流出396.3万元。该股近5个交易日上涨4.53%，主力资金累计净流入56.4万元；近20日主力资金累计净流出680.1万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715170222a6aabc3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715170222a6aabc3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2551963909","title":"昭衍新药07月14日主力净流出396.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2551963909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551963909?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:15","pubTimestamp":1752480919,"startTime":"0","endTime":"0","summary":"07月14日, 昭衍新药股价跌0.72%，报收20.70元，成交金额1.6亿元，换手率6.45%，振幅7.24%，量比0.73。昭衍新药今日主力资金净流出396.3万元，上一交易日主力净流入1230.7万元。该股近5个交易日上涨13.51%，主力资金累计净流入995.5万元；近20日主力资金累计净流入926.0万元，其中净流入天数为11日。该股主力净额占比0.16%，港股市场排名2633/2673。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714165619a44975d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714165619a44975d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","06127"],"gpt_icon":0},{"id":"2550365249","title":"昭衍新药07月11日获主力加仓1230.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550365249","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550365249?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:16","pubTimestamp":1752221761,"startTime":"0","endTime":"0","summary":"07月11日, 昭衍新药股价涨5.52%，报收20.85元，成交金额2.2亿元，换手率8.80%，振幅11.69%，量比1.09。昭衍新药今日主力资金净流入1230.7万元，上一交易日主力净流入260.2万元。该股近5个交易日上涨15.70%，主力资金累计净流入1257.1万元；近20日主力资金累计净流入1663.6万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171002a44475b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171002a44475b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2550605368","title":"港股异动 | CRO概念股集体走强 药明康德(02359)上半年业绩预喜 机构称CXO企业机遇充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2550605368","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550605368?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:43","pubTimestamp":1752198194,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股集体走强，截至发稿，凯莱英涨13.59%，报89.45港元；药明康德涨9.15%，报87.1港元；昭衍新药涨8.81%，报27.5港元；康龙化成涨6.86%，报18.08港元；药明生物涨3.5%，报26.6港元。消息面上，药明康德发盈喜，预计2025年上半年实现营业收入约人民币207.99亿元，同比增长约20.64%；预计归属于公司股东的净利润约人民币85.61亿元，同比增长约101.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1316564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","02359","LU0823426308.USD","LU1997245094.SGD","LU0326950275.SGD","LU1688375341.USD","LU0819121731.USD","LU1997245177.USD","LU0039217434.USD","LU0979878070.USD","LU0051755006.USD","LU0140636845.USD","SG9999002562.SGD","BK1521","LU0348735423.USD","LU2242644610.SGD","03759","LU0572944931.SGD","LU0516423091.SGD","LU0359202008.SGD","LU0043850808.USD","LU0516422366.SGD","LU0516422440.USD","LU0052750758.USD","LU0359201612.USD","06127","LU0856984785.SGD","LU0516422952.EUR","LU1969619763.USD","BK1583","LU0516423174.USD","603259","LU1242518931.SGD","SG9999002463.SGD","02269","CXO","LU0588546209.SGD","LU2125910500.SGD","LU0417516738.SGD","LU0320764599.SGD","BK1191","LU0456827905.SGD","LU2039709279.SGD","LU0456842615.SGD","IE00B0JY6N72.USD","LU0327786744.USD","LU0456846285.SGD","BK0216","06821","LU1046422090.SGD"],"gpt_icon":0},{"id":"2550912636","title":"昭衍新药盘中异动 股价大涨5.14%报20.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550912636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550912636?lang=zh_cn&edition=full","pubTime":"2025-07-10 11:58","pubTimestamp":1752119917,"startTime":"0","endTime":"0","summary":"2025年07月10日临近午盘11时58分，昭衍新药股票出现异动，股价急速拉升5.14%。截至发稿，该股报20.650港元/股，成交量486.407万股，换手率4.09%，振幅7.08%。资金方面，该股资金流入4718.61万港元，流出2873.74万港元。昭衍新药股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，奥星生命科技、北海康成-B、三叶草生物-B涨幅较大，振幅较大的相关个股有奥星生命科技、北海康成-B、正大企业国际，振幅分别为23.19%、21.74%、18.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710115837a441a5f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710115837a441a5f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","06127"],"gpt_icon":0},{"id":"2550638294","title":"尾盘A股突变！银行板块再度走强 创新药概念盘中走势活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2550638294","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550638294?lang=zh_cn&edition=full","pubTime":"2025-07-09 17:41","pubTimestamp":1752054093,"startTime":"0","endTime":"0","summary":"银行板块强势银行板块今日再度走强，截至收盘，厦门银行涨逾4%，渝农商行、张家港行涨约3%。值得注意的是，工商银行、农业银行等盘中均创出新高。创新药概念活跃创新药概念盘中走势活跃，截至收盘，普蕊斯涨超17%，盘中一度20%涨停；美迪西涨超13%，九芝堂涨停，昭衍新药、恒瑞医药涨超7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709174156953bfc55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709174156953bfc55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","06978","601288","688202","601398","BK1576","BK1161","BK1574","600276","BK1141"],"gpt_icon":0},{"id":"2550878666","title":"AH股溢折价盘点：弘业期货、昭衍新药、钧达股份溢折价率升幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2550878666","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550878666?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:51","pubTimestamp":1752051080,"startTime":"0","endTime":"0","summary":"截至7月9日收盘，共172只A股较其港股溢价，3只A股较其港股折价；其中，弘业期货、比亚迪、比亚迪溢价率居前，溢价率依次为224.75%、222.93%、222.93%，宁德时代、恒瑞医药、药明康德折价，折价率为22.82%、9.84%、2.88%。与上一交易日相比，共103只A股溢折价率上升，共71只A股溢折价率下降。其中，弘业期货、昭衍新药、钧达股份溢折价率升幅居前，依次上升1347BP、831BP、791BP，峰岹科技、蓝思科技、中国能建溢折价率降幅居前，依次下降2380BP、1533BP、1194BP。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165200a43fefa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165200a43fefa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","02865","BK1141","BK1147","BK1564","BK1576","03678","BK1163"],"gpt_icon":0},{"id":"2550506101","title":"CRO指数盘中涨幅扩大至3%，美迪西涨停，昭衍新药、毕得医药、阳光诺和、益诺思跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550506101","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550506101?lang=zh_cn&edition=full","pubTime":"2025-07-09 11:05","pubTimestamp":1752030351,"startTime":"0","endTime":"0","summary":"CRO指数盘中涨幅扩大至3%，美迪西涨停，昭衍新药、毕得医药、阳光诺和、益诺思跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/09110551578183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","688621","688202","688073","BK1576","06127","BK0216","688710","603127"],"gpt_icon":0},{"id":"2550055995","title":"昭衍新药盘中异动 早盘大幅上涨5.05%报20.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550055995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550055995?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:26","pubTimestamp":1752027998,"startTime":"0","endTime":"0","summary":"2025年07月09日早盘10时26分，昭衍新药股票出现异动，股价大幅拉升5.05%。截至发稿，该股报20.400港元/股，成交量334.957万股，换手率2.81%，振幅8.08%。资金方面，该股资金流入2886.75万港元，流出2312.79万港元。最近的财报数据显示，该股实现营业收入3.11亿港元，净利润4,455.80万港元，每股收益0.0542港元，毛利8,907.85万港元，市盈率191.14倍。昭衍新药股票所在的生物技术行业中，整体涨幅为1.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709102638a43f30a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709102638a43f30a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2549595215","title":"CRO/CMO概念震荡反弹，美迪西涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2549595215","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549595215?lang=zh_cn&edition=full","pubTime":"2025-07-08 11:23","pubTimestamp":1751945013,"startTime":"0","endTime":"0","summary":"7月8日，CRO/CMO概念震荡反弹，美迪西涨停，昭衍新药、华测检测、益诺思、泰格医药、诺思格、和元生物等跟涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507083450862638.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507083450862638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","03347","BK1141","06127","BK1576"],"gpt_icon":0},{"id":"2549567807","title":"昭衍新药盘中异动 早盘大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549567807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549567807?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:38","pubTimestamp":1751938724,"startTime":"0","endTime":"0","summary":"2025年07月08日早盘09时38分，昭衍新药股票出现波动，股价急速上涨5.03%。截至发稿，该股报19.200港元/股，成交量55.73万股，换手率0.47%，振幅6.56%。资金方面，该股资金流入513.646万港元，流出269.345万港元。昭衍新药股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，基石药业-B、正大企业国际、荣昌生物涨幅较大，振幅较大的相关个股有基石药业-B、北海康成-B、创胜集团-B，振幅分别为18.57%、9.30%、9.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093844953a3556&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093844953a3556&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2549561112","title":"被牛市遗忘的CXO，谁将凭“拐点基因”破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2549561112","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549561112?lang=zh_cn&edition=full","pubTime":"2025-07-08 08:07","pubTimestamp":1751933234,"startTime":"0","endTime":"0","summary":"二级市场创新药的火热反衬出CXO的落寞。到了6月底，恒生港股通创新药指数宣布修订编制方案，剔除CXO企业，聚焦创新药核心公司。01和创新药脱钩的CXO二级市场股价走势反差的背后，是双方走到了不同的发展阶段。如今，二者明显分化的走势意味着CXO行业也走到了转型的关键节点。03业务的此消彼长业务结构性变化正在重塑CXO行业竞争格局。也就是说，临床CRO业务还将继续承压，当新开临床试验数量持续减少，内卷或更加严重。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708083555a43cb692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708083555a43cb692&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","06127","06821","01801","03759","09926","688336","BK1161","BK1191","03347","BK1574","688710","BK1141","02359","BK1576","BK1583","06978"],"gpt_icon":0},{"id":"2549283535","title":"国产首个丨昭衍新药助力正大天晴重组人凝血因子Ⅶa获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2549283535","media":"昭衍JOINN","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549283535?lang=zh_cn&edition=full","pubTime":"2025-07-07 17:30","pubTimestamp":1751880644,"startTime":"0","endTime":"0","summary":"昭衍助力首个国产重组人凝血因子Ⅶa类生物制品获批上市！重组人凝血因子Ⅶa因其高效止血作用和独特的旁路效应，已成为抑制物阳性患者的重要治疗选择[3]，并在全球范围内得到广泛应用。此前，正大天晴注射用重组人凝血因子Ⅷ（安恒吉）已获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707182753a43ba61f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707182753a43ba61f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","BK0216","06127"],"gpt_icon":0},{"id":"2549893265","title":"7月7日昭衍新药创60日新高，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549893265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549893265?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:22","pubTimestamp":1751876567,"startTime":"0","endTime":"0","summary":"证券之星消息，7月7日昭衍新药创60日新高，收盘报22.86元，当日涨2.24%，换手率4.95%，成交量31.22万手，成交额6.91亿元。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共17家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为44.75亿元，最新净值4.084，较上一交易日上涨2.92%，近一年上涨43.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700020785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0216","BK1576","06127","603127"],"gpt_icon":0},{"id":"2549309372","title":"乐普医疗、昭衍新药等新设华夏致远创投基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2549309372","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549309372?lang=zh_cn&edition=full","pubTime":"2025-07-07 11:35","pubTimestamp":1751859345,"startTime":"0","endTime":"0","summary":"人民财讯7月7日电，企查查APP显示，近日，华夏致远创业投资基金（北京）合伙企业（有限合伙）成立，经营范围包含：创业投资（限投资未上市企业）；以私募基金从事股权投资、投资管理、资产管理等活动。企查查股权穿透显示，该企业由乐普医疗、昭衍新药等共同出资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707113546a43aeb64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707113546a43aeb64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","BK0196","06127","BK0251","BK0113","BK0114","BK0188","300003","BK0216","BK0028","BK0042","BK0201"],"gpt_icon":0},{"id":"2549434490","title":"每周股票复盘：昭衍新药（603127）参与投资设立基金及股本情况更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2549434490","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549434490?lang=zh_cn&edition=full","pubTime":"2025-07-06 01:49","pubTimestamp":1751737747,"startTime":"0","endTime":"0","summary":"本周，昭衍新药7月1日盘中最高价报22.76元。本周关注点公司公告汇总：昭衍新药计划投资不超过2000万人民币参与华夏致远创业投资基金。H股公告：截至2025年6月30日，昭衍新药H股和A股的法定注册股本分别为118,995,206股和630,482,128股。H股公告北京昭衍新药研究中心股份有限公司提交了截至2025年6月30日的证券变动月报表。已发行股份方面，H股已发行股份总数保持在118,995,206股，无库存股；A股已发行股份总数为630,482,128股，其中库存股为3,303,034股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600000163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0216","BK1576","603127","06127"],"gpt_icon":0},{"id":"2549311388","title":"北京昭衍新药H股及A股股本结构披露 6月新增330万股A股流通股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549311388","media":"中访网数据","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549311388?lang=zh_cn&edition=full","pubTime":"2025-07-05 08:40","pubTimestamp":1751676039,"startTime":"0","endTime":"0","summary":"中访网数据  北京昭衍新药研究中心股份有限公司于2025年7月4日向香港交易所提交了截至2025年6月30日的证券变动月报表。数据显示，公司A股普通股本月新增流通股330.3万股，总流通股数增至6.3048亿股，而H股数量维持1.1899亿股不变。此次股本变动未对H股结构产生影响，两地上市股份的权益分配保持独立。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070508513195371958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070508513195371958&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","399300","159982","BK0216","603127"],"gpt_icon":0},{"id":"2548809903","title":"昭衍新药07月03日主力净流入341.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2548809903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548809903?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:15","pubTimestamp":1751530559,"startTime":"0","endTime":"0","summary":"07月03日, 昭衍新药股价涨0.58%，报收17.26元，成交金额7873.8万元，换手率3.85%，振幅5.48%，量比0.62。该股近5个交易日上涨7.95%，主力资金累计净流出1117.4万元；近20日主力资金累计净流入2603.6万元，其中净流入天数为12日。该股主力净额占比0.17%，港股市场排名46/2670。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703171018a4cd001d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703171018a4cd001d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","BK1576"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.048},{"period":"1month","weight":0.4421},{"period":"3month","weight":1.236},{"period":"6month","weight":1.6925},{"period":"1year","weight":1.9583},{"period":"ytd","weight":1.3414}],"compareEarnings":[{"period":"1week","weight":0.0284},{"period":"1month","weight":0.047},{"period":"3month","weight":0.1603},{"period":"6month","weight":0.2676},{"period":"1year","weight":0.3964},{"period":"ytd","weight":0.2376}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.111186},{"month":2,"riseRate":0.75,"avgChangeRate":0.137943},{"month":3,"riseRate":0.4,"avgChangeRate":-0.007614},{"month":4,"riseRate":0.2,"avgChangeRate":-0.110118},{"month":5,"riseRate":0.8,"avgChangeRate":0.111301},{"month":6,"riseRate":0.6,"avgChangeRate":0.067356},{"month":7,"riseRate":0.8,"avgChangeRate":0.080202},{"month":8,"riseRate":0,"avgChangeRate":-0.164045},{"month":9,"riseRate":0.5,"avgChangeRate":0.001112},{"month":10,"riseRate":0.25,"avgChangeRate":-0.06138},{"month":11,"riseRate":0.5,"avgChangeRate":0.080696},{"month":12,"riseRate":0.5,"avgChangeRate":-0.057472}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}